B&D White Capital Company’s Sanofi SNY Stock Holding History

B&D White Capital Company’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,400	Closed	-$319K	–	117
2022 Q3	$319K	Buy	+8,400	New	+$374K	0.12%	52

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

B&D White Capital Company's SNY Position: Q4 2022 in Review

B&D White Capital Company sold out of Sanofi (SNY) in Q4 2022, closing a stake of 8,400 shares — an estimated $319K sold.

B&D White Capital Company first reported a position in SNY in Q3 2022 and held it in 1 quarter. The position peaked at $319K in Q3 2022. 643 funds tracked by Wall St. Rank hold SNY as of Q4 2022.

B&D White Capital Company reported no remaining Sanofi position as of Q4 2022 after selling out during the quarter.
B&D White Capital Company sold 8,400 Sanofi shares in Q4 2022, an estimated $319K.
B&D White Capital Company first reported a position in Sanofi in Q3 2022 and held it in 1 quarter.
B&D White Capital Company's Sanofi position peaked at $319K in Q3 2022.
643 funds tracked by Wall St. Rank held Sanofi as of Q4 2022.

Based on B&D White Capital Company's 13F filing for Q4 2022, filed 7 Feb 2023.